openPR Logo
Press release

Rethinking Acne: Texas-Based Practitioner Offers Root-Cause Approach Amid Rising Industry Costs

06-23-2025 11:18 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Rethinking Acne: Texas-Based Practitioner Offers Root-Cause

Dallas-Fort Worth, TX - Jun 23, 2025 - As the U.S. acne treatment market continues to grow-projected to reach $7.27 billion by 2030-one Texas-based consultant is offering a radically different path forward, focused not on topical fixes or pharmaceuticals, but on the body's own internal signals.

Michelle Valeri, founder of MV Skin Consulting and a best-selling author, has spent years developing a method of acne treatment that views breakouts not as isolated skin problems, but as indicators of deeper systemic imbalances. Her approach, now gaining traction in Collin and Dallas counties, is grounded in functional analysis and personalized care.

"Acne is often misunderstood as purely a cosmetic issue," says Valeri. "In reality, it's a form of communication-one the body uses to indicate something isn't working properly."

Unlike traditional dermatology or aesthetics practices, which typically cite four stages of acne caused by oil, bacteria, and cellular turnover, Valeri's method recognizes 12 distinct acne types and over 25 possible root causes. Treatments are customized for each individual, without the use of prescriptions, supplements, or product-heavy routines.

A Shift from Conventional Treatment

MV Skin Consulting serves clients across Plano, Allen, McKinney, Richardson, and North Dallas. Valeri avoids one-size-fits-all protocols, offering instead a supportive, in-depth approach that often includes digestive, hormonal, or environmental evaluations. Clients report not only clearer skin but also improvements in confidence and overall well-being.

The practice also stands apart by not using extractions, chemical peels, or treatments that lead to sensitivity or discomfort-a key difference from many skin care clinics.

In addition to client services, Valeri operates an educational institute for estheticians and health professionals, training them in her root-cause acne system. Since 2018, the school has helped thousands of providers deepen their understanding of the body's signals and refine their treatment strategies.

What's Ahead

Valeri's first book, "Betrayal by the Billions," achieved #1 bestseller status on Amazon. A follow-up volume, "The Acne Edition," is currently in development and expected for release in late 2025.

MV Skin Consulting is positioning itself as a trusted option for those seeking sustainable acne solutions outside the conventional model-especially for teens and adults seeking confidence without prescriptions or pain.

For more information, visit http://www.MVSkinConsulting.com or

contact Michelle Valeri directly at Send Email [https://www.abnewswire.com/email_contact_us.php?pr=rethinking-acne-texasbased-practitioner-offers-rootcause-approach-amid-rising-industry-costs]
Country: United States
Website: http://MVSkinConsulting.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rethinking Acne: Texas-Based Practitioner Offers Root-Cause Approach Amid Rising Industry Costs here

News-ID: 4078687 • Views:

More Releases from ABNewswire

The Historical Novel
The Historical Novel "Thunder in the Wind" investigates what happens to a people …
Author Curt Orloff's sweeping tale of deculturization delivers a timeless message of resilience, relevance, and reckoning In Thunder in the Wind [https://www.amazon.com/Thunder-Wind-Curt-Orloff/dp/1963565347/ref=monarch_sidesheet_image], author Curt Orloff delivers an unflinching portrait of a people caught in the storm of historical transformation. Set mostly on the Fort Belknap reservation in Montana in the late 1800s, this novel explores how ordinary people responded to the tumultuous situation of an indifferent bureaucracy and a society blinded
SharePay Launches on Indiegogo to Simplify Group Payments Like Never Before
SharePay Launches on Indiegogo to Simplify Group Payments Like Never Before
Los Angeles, CA - June 23, 2025 - Today marks the launch of SharePay, a revolutionary new way to split payments without stress, available now on Indiegogo [file:///C:/Users/19719/Desktop/Sharepay%20Press%20release%20content.docx#/]. Whether you're planning a group trip, ordering takeout with friends, or contributing to a shared gift, SharePay makes it easy to pay together - even when not everyone can pay right away. Unlike traditional payment apps, SharePay doesn't just split bills - it
Bronchiectasis Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Companies by DelveInsight
Bronchiectasis Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, …
Bronchiectasis Companies are Insmed, AstraZeneca, Zambon, Renovion, Haisco Pharmaceutical Group, Chiesi Farmaceutici S.p.A, Armata Pharmaceuticals, Verona Pharma, Sanofi, Regeneron Pharmaceuticals, Boehringer Ingelheim, CSL, and others. (Albany, USA) DelveInsight's "Bronchiectasis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of bronchiectasis, historical and forecasted epidemiology, as well as the bronchiectasis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. The
Antiphospholipid Syndrome Drugs Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical Trials, Epidemiology, Therapies, Companies by DelveInsight
Antiphospholipid Syndrome Drugs Market 2034: EMA, PDMA, FDA Approvals, Medicatio …
Antiphospholipid Syndrome Companies included are Novartis AG, Fresenius Kabi AG, Akorn Incorporated, Teva Pharmaceutical Industries Ltd, Mylan N.V, Johnsons & Johnsons Pvt Ltd, F. Hoffman-La Roche Ltd., Lilly, Merck & Co., Inc., Aurobindo Pharma, Shenzhen Techdow Pharmaceutical Co., Ltd, Bayer AG, AstraZeneca, and several others. (Albany, USA) DelveInsight's "Antiphospholipid Syndrome Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Antiphospholipid Syndrome, historical and forecasted epidemiology as well

All 5 Releases


More Releases for Valeri

Global Balsamic Vinegar Market Share, Growth & Analysis – Forecasts To 2026
The market report is designed to provide a complete view of the global Balsamic Vinegar Market. This business intelligence report has been categorized into qualitative and quantitative insights over the forecast period (2018-2026). Request for a sample copy of the report @: https://www.globalmarketestimates.com/global-balsamic-vinegar-market-size/ The report provides the following market insights which enable the enterprises and consumers to make strategic business decisions - Strategic Market Entry - We provide detailed research support to
Italy Balsamic Vinegar Market Share, Growth & Analysis – Forecasts To 2026
The market report is designed to provide a complete view of the Italy Balsamic Vinegar Market. This business intelligence report has been categorized into qualitative and quantitative insights over the forecast period (2018-2026). Request for a sample copy of the report @: https://www.globalmarketestimates.com/italy-balsamic-vinegar-market-size/ The report provides the following market insights which enable the enterprises and consumers to make strategic business decisions - Strategic Market Entry - We provide detailed research support to
SMi’s 3D Cell Culture announces key industry speakers and agenda released
SMi’s Pharma is proud to announce the 3rd Annual 3D Cell Culture is back and the conference is taking place at the Copthorne Tara Hotel in London, UK on 20th and 21st February 2019. Proudly sponsored by InoCure & TEDD Competence Centre Proud to announce the Co-Chairs for the conference Nicola Valeri, Gastrointestinal Cancer Biology and Genomics Team Leader, The Institute of Cancer Research and Stefan Przyborski, Professor of Cell Technology, University
arvato Systems presents leading publishing solutions at the IFRA World Publishin …
arvato Systems appearing at the IFRA • arvato subsidiary presents innovative solutions for publishing companies, in cooperation with hybris, mediaspectrum and SAP • arvato Systems provides exceptional quality as an SAP Gold Partner, hybris Platinum Partner and mediaspectrum Integrator (arvato Systems) Gütersloh – arvato Systems is appearing again this year at the IFRA World Publishing Expo, the leading international trade fair for newspapers and magazines, taking place in Berlin from
Canadian Restaurant Group Selects Lx Contracts from Lucernex For Its Lease Admin …
Dallas, TX (February 5, 2013) – Lucernex Technologies announced today that one of Canada's largest full service restaurant companies has selected Lucernex’s cloud-based Lx Contracts solution to manage its multi-brand portfolio of over 700 restaurants across Canada. Lx Contracts will replace their legacy system RetaiLease. “After we have completed this data conversion we will have successfully converted every major legacy lease administration system and integrated the conversion mapping into our toolkit”,
Lucernex Technologies announced today that Aaron’s, Inc. (NYSE: AAN) has selec …
Dallas, TX– Lucernex Technologies announced today that Aaron’s, Inc. (NYSE: AAN) has selected Lucernex’s Lx Retail to manage its over 1,800 Company-operated and franchised stores in 48 states and Canada. “After evaluating our operational requirements, we realized that we needed more than just a replacement for our legacy lease administration system. We needed an integrated approach to managing our real estate. Lucernex offers a solution that will allow